Fuhrman Nuclear Grade for Clear Cell Renal Carcinoma
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Grade 11–1
- Grade 22–2
- Grade 33–3
- Grade 44–4
The Fuhrman Nuclear Grade for Clear Cell Renal Carcinoma calculates evaluating lower urinary tract symptoms, nephrolithiasis burden, and prostate cancer risk. Key inputs include nuclear diameter. Scores guide initiating medical expulsive or alpha-blocker therapy, ordering renal imaging, or scheduling surgical intervention. Routine clinical application promotes standardized evidence-based patient management.
Clinical Guidelines & Evidence
Provides prognostic grading system for clear cell renal cell carcinoma (RCC) based on nuclear morphology and cellular appearance. Independent predictor of cancer-specific survival that correlates nuclear grade with prognosis.
Clinical Indication
The Fuhrman Nuclear Grade for Clear Cell Renal Carcinoma is indicated for bedside clinical practice to support Provides prognostic grading system for clear cell renal cell carcinoma (RCC) based on nuclear morphology and cellular appearance. Independent predictor of cancer-specific survival that correlates nuclear grade with prognosis.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with renal colic, hematuria, benign prostatic hyperplasia (BPH), or urogenital malignancies. Clinical application is indicated across Urology clinics, shock wave lithotripsy suites, and acute urologic surgical services.
Limitations & Contraindications
Serum PSA levels can be transiently elevated by acute prostatitis, urinary retention, or recent instrumentation.
Clinical Pearls & Action Plan
Obstructive urolithiasis complicated by upper urinary tract infection represents a surgical emergency requiring urgent decompression. Guideline pearl: The WHO/ISUP grading system is now recommended over Fuhrman grading for better prognostic accuracy.
Grading based on nuclear diameter, shape, nucleoli visibility, and presence of bizarre features. Grade 1-3 determined by worst feature among the first three parameters. Grade 4 if bizarre/multilobed nuclei or spindle cells present.
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| nuclear_diameter | string | Yes | Size of tumor cell nuclei compared to lymphocytes |
| nuclear_shape | string | Yes | Shape and regularity of nuclear outline |
| nucleoli | string | Yes | Visibility and prominence of nucleoli |
| bizarre_multilobed_spindle | string | Yes | Presence of bizarre, multilobed nuclei or spindle cells |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 1–1 | Grade 1 | Small nuclei, round and uniform |
| 2–2 | Grade 2 | Slightly irregular nuclei with visible nucleoli |
| 3–3 | Grade 3 | Obviously irregular nuclei with prominent nucleoli |
| 4–4 | Grade 4 | Pleomorphic nuclei with extreme features |
Evidence-Based References (EBM)
- Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982 Oct;6(7):655-63. doi: 10.1097/00000478-198210000-00007.DOI: 10.1097/00000478-198210000-00007
- Rioux-Leclercq N, Karakiewicz PI, Trinh QD, Ficarra V, Cindolo L, de la Taille A, et al. Prognostic ability of simplified nuclear grading of renal cell carcinoma. Cancer. 2007 Mar 1;109(5):868-74. doi: 10.1002/cncr.22463.DOI: 10.1002/cncr.22463
- Delahunt B, Cheville JC, Martignoni G, Humphrey PA, Magi-Galluzzi C, McKenney J, et al. The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol. 2013 Oct;37(10):1490-504. doi: 10.1097/PAS.0b013e318299f0fb.DOI: 10.1097/PAS.0b013e318299f0fb